\-\ Texto\\:\\ \ \(0\)\
\-\ labs\\:\ \(4\)\
\-\ a1\\-fetoprot\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 6\\.5\\ ng\\/ml\ \(0\)\
\-\ cea\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 1\\.6\\ ng\\/ml\ \(0\)\
\-\ ca\\ 19\\-9\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ 33\\ u\\/ml\ \(0\)\
\-\ albumin\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 4\\.1\\ g\\/dl\ \(0\)\
\-\ alk\\ phos\\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ 87\\ u\\/l\ \(0\)\
\-\ ast\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ 28\\ u\\/l\ \(0\)\
\-\ alt\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ 32\\ u\\/l\ \(0\)\
\-\ tbili\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 0\\.4\\ mg\\/dl\ \(0\)\
\-\ amylase\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ 84\\ u\\/l\ \(0\)\
\-\ lipase\\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 193\\ u\\/l\ \(0\)\
\-\ patient\\ is\\ undergoing\\ workup\\ for\\ neoplasm\\.\ \(0\)\
\-\ contrast\\ axial\\ images\\ of\\ the\\ abdomen\\ demonstrate\\ a\\ filling\\ defect\\ of\\ the\\ right\\ gonadal\\ vein\\ extending\\ from\\ the\\ level\\ of\\ the\\ right\\ renal\\ vein\\ to\\ the\\ pelvis\\.\ \(0\)\
\-\ ovarian\\ vein\\ thrombosis\ \(2\)\
\-\ n\\/a\ \(127\)\
\-\ 38\\ year\\ old\\ asian\\ female\\ with\\ a\\ long\\ standing\\ history\\ of\\ refractory\\ hypertension\\ and\\ prior\\ history\\ of\\ pancreatitis\\ presents\\ with\\ right\\ upper\\ quadrant\\ pain\\ into\\ the\\ emergency\\ medical\\ department\\.\ \(1\)\
\-\ right\\ upper\\ quadrant\\ ultrasound\\ demonstrated\\ a\\ retroperitoneal\\ mass\\ in\\ the\\ region\\ of\\ the\\ pancreatic\\ head\\ with\\ extension\\ into\\ the\\ porta\\ hepatis\\.\\ \\ provision\\ diagnosis\\ of\\ malignancy\\,\\ undergoing\\ workup\\.\ \(0\)\
\-\ ovarian\\ vein\\ thrombosis\\ is\\ cited\\ as\\ a\\ rare\\ finding\\ in\\ post\\ partum\\ women\\ and\\ incidentally\\ in\\ patients\\ with\\ extensive\\ pelvic\\ surgery\\.\\ \\ complications\\ include\\ \\"perivenous\\ phlegmon\\ formation\\ with\\ hydronephrosis\\,\\ sepsis\\,\\ septic\\ pulmonary\\ thromboembolism\\,\\ caval\\ thrombosis\\,\\ and\\ death\\.\\"\ \(0\)\
\-\ this\\ patient\\ presented\\ with\\ a\\ presumptive\\ malignancy\\ involving\\ pancreas\\.\\ \\ secondary\\ to\\ the\\ hypercoagulability\\ in\\ malignancy\\,\\ this\\ is\\ the\\ probably\\ etiology\\ of\\ this\\ disease\\.\\ \\ \ \(0\)\
\-\ smith\\,\\ m\\.\\,\\ felker\\,\\ r\\.\\,\\ emerson\\,\\ d\\.\\,\\ livingston\\,\\ j\\.\\ and\ \(0\)\
\-\ egerman\\,\\ r\\.\\ \\"sonographic\\ visualization\\ of\\ ovarian\\ veins\\ during\\ the\\ puerperium\\:\\ an\\ assessment\\ of\\ efficacy\\"\\.\\ \\ american\\ journal\\ of\\ obstetrics\\ and\\ gynecology\\.\\ \\ may\\ 2002\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ u\\/l\\:\\ 0\\.07791318130721966\ \(0\)\
\-\ vein\\:\\ 0\\.037029141581007396\ \(0\)\
\-\ ovarian\\:\\ 0\\.03512194891192876\ \(0\)\
\-\ ng\\/ml\\:\\ 0\\.03401212100621167\ \(0\)\
\-\ thrombosis\\:\\ 0\\.03294632287862016\ \(0\)\
\-\ malignancy\\:\\ 0\\.02965948812396571\ \(0\)\
\-\ a1\\-fetoprot\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ provision\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ perivenous\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ felker\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ emerson\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ egerman\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ puerperium\\:\\ 0\\.026393767736426644\ \(0\)\
\-\ workup\\:\\ 0\\.026327412072873653\ \(0\)\
\-\ undergoing\\:\\ 0\\.02509308748911513\ \(0\)\
\-\ livingston\\:\\ 0\\.024318476776666327\ \(0\)\
\-\ 193\\:\\ 0\\.023104509387120924\ \(0\)\
\-\ caval\\:\\ 0\\.02224318581690601\ \(0\)\
\-\ 19\\-9\\:\\ 0\\.021575091351893408\ \(0\)\
\-\ obstetrics\\:\\ 0\\.021575091351893408\ \(0\)\
\-\ cited\\:\\ 0\\.021029218427360608\ \(0\)\
\-\ partum\\:\\ 0\\.021029218427360608\ \(0\)\
\-\ u\\/ml\\:\\ 0\\.020167894857145697\ \(0\)\
\-\ hepatis\\:\\ 0\\.019815251037815205\ \(0\)\
\-\ thromboembolism\\:\\ 0\\.019815251037815205\ \(0\)\
\-\ hypercoagulability\\:\\ 0\\.019815251037815205\ \(0\)\
\-\ gynecology\\:\\ 0\\.01949980039213309\ \(0\)\
\-\ gonadal\\:\\ 0\\.019214440572359666\ \(0\)\
\-\ porta\\:\\ 0\\.019214440572359666\ \(0\)\
\-\ cea\\:\\ 0\\.018492398486081557\ \(0\)\
\-\ phlegmon\\:\\ 0\\.01828583300258769\ \(0\)\
\-\ 6\\.5\\:\\ 0\\.01809260389738538\ \(0\)\
\-\ quadrant\\:\\ 0\\.018008239125664998\ \(0\)\
\-\ efficacy\\:\\ 0\\.0179110930536236\ \(0\)\
\-\ 4\\.1\\:\\ 0\\.017424509432372778\ \(0\)\
\-\ 87\\:\\ 0\\.017424509432372778\ \(0\)\
\-\ presumptive\\:\\ 0\\.017424509432372778\ \(0\)\
\-\ g\\/dl\\:\\ 0\\.017278431096536154\ \(0\)\
\-\ tbili\\:\\ 0\\.017278431096536154\ \(0\)\
\-\ 0\\.4\\:\\ 0\\.01713914961259935\ \(0\)\
\-\ asian\\:\\ 0\\.01663898768247011\ \(0\)\
\-\ albumin\\:\\ 0\\.01652599268850949\ \(0\)\
\-\ r\\.\\:\\ 0\\.01652599268850949\ \(0\)\
\-\ 84\\:\\ 0\\.016112368920602853\ \(0\)\
\-\ 1\\.6\\:\\ 0\\.016017312937625063\ \(0\)\
\-\ refractory\\:\\ 0\\.015835802093863285\ \(0\)\
\-\ amylase\\:\\ 0\\.015749013061308638\ \(0\)\
\-\ sepsis\\:\\ 0\\.015749013061308638\ \(0\)\
\-\ lipase\\:\\ 0\\.015664669118294578\ \(0\)\
\-\ d\\.\\:\\ 0\\.015203140136775838\ \(0\)\
\-\ j\\.\\:\\ 0\\.015063858652839034\ \(0\)\
\-\ m\\.\\:\\ 0\\.014996574653281972\ \(0\)\
\-\ alk\\:\\ 0\\.01493076954334552\ \(0\)\
\-\ phos\\:\\ 0\\.01493076954334552\ \(0\)\
\-\ journal\\:\\ 0\\.01450666619884544\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.01439576418782643\ \(0\)\
\-\ smith\\:\\ 0\\.014236752734790657\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.014037077960842536\ \(0\)\
\-\ 2002\\:\\ 0\\.013989172747230437\ \(0\)\
\-\ ast\\:\\ 0\\.013895602257697188\ \(0\)\
\-\ alt\\:\\ 0\\.013895602257697188\ \(0\)\
\-\ death\\:\\ 0\\.013804867678369859\ \(0\)\
\-\ assessment\\:\\ 0\\.01376051113410297\ \(0\)\
\-\ 38\\:\\ 0\\.013631253134506536\ \(0\)\
\-\ standing\\:\\ 0\\.013631253134506536\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.013631253134506536\ \(0\)\
\-\ probably\\:\\ 0\\.013631253134506536\ \(0\)\
\-\ visualization\\:\\ 0\\.013507345301683618\ \(0\)\
\-\ septic\\:\\ 0\\.013427500250539424\ \(0\)\
\-\ 33\\:\\ 0\\.013273927512852146\ \(0\)\
\-\ pancreas\\:\\ 0\\.013092416669090366\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.012888200351645656\ \(0\)\
\-\ 32\\:\\ 0\\.01275940578552682\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.012575658907974954\ \(0\)\
\-\ pancreatic\\:\\ 0\\.012517333639930727\ \(0\)\
\-\ women\\:\\ 0\\.012431375239085125\ \(0\)\
\-\ sonographic\\:\\ 0\\.012403262244025725\ \(0\)\
\-\ upper\\:\\ 0\\.012347787457297716\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.012333829353187085\ \(0\)\
\-\ veins\\:\\ 0\\.012239911991778915\ \(0\)\
\-\ american\\:\\ 0\\.0121873841185726\ \(0\)\
\-\ into\\:\\ 0\\.012175606993770701\ \(0\)\
\-\ 28\\:\\ 0\\.012059960123306745\ \(0\)\
\-\ ca\\:\\ 0\\.011913881787470122\ \(0\)\
\-\ r\\:\\ 0\\.011619893685137146\ \(0\)\
\-\ incidentally\\:\\ 0\\.011598431141788006\ \(0\)\
\-\ department\\:\\ 0\\.011472789827120246\ \(0\)\
\-\ \\,\\:\\ 0\\.011347128494736595\ \(0\)\
\-\ etiology\\:\\ 0\\.010829405367367284\ \(0\)\
\-\ right\\:\\ 0\\.010797984540244512\ \(0\)\
\-\ formation\\:\\ 0\\.010560632913987913\ \(0\)\
\-\ pelvic\\:\\ 0\\.010500750678339202\ \(0\)\
\-\ \\.\\:\\ 0\\.010416031549520763\ \(0\)\
\-\ filling\\:\\ 0\\.010300119809228542\ \(0\)\
\-\ extensive\\:\\ 0\\.010231603959427382\ \(0\)\
\-\ complications\\:\\ 0\\.010138241901233705\ \(0\)\
\-\ hypertension\\:\\ 0\\.010086170815270025\ \(0\)\
\-\ rare\\:\\ 0\\.009935180235548792\ \(0\)\
\-\ emergency\\:\\ 0\\.009687989814312204\ \(0\)\
\-\ defect\\:\\ 0\\.009577087803293194\ \(0\)\
\-\ pelvis\\:\\ 0\\.00929668085805877\ \(0\)\
\-\ n\\/a\\:\\ 0\\.009267085770536188\ \(0\)\
\-\ extension\\:\\ 0\\.009132716530483993\ \(0\)\
\-\ involving\\:\\ 0\\.008977267257494892\ \(0\)\
\-\ labs\\:\\ 0\\.008898125769266881\ \(0\)\
\-\ long\\:\\ 0\\.008821022487523126\ \(0\)\
\-\ neoplasm\\:\\ 0\\.008713043640454875\ \(0\)\
\-\ this\\:\\ 0\\.00863296898186347\ \(0\)\
\-\ extending\\:\\ 0\\.008600955236047297\ \(0\)\
\-\ finding\\:\\ 0\\.008245693128857728\ \(0\)\
\-\ post\\:\\ 0\\.008056392314587706\ \(0\)\
\-\ medical\\:\\ 0\\.007872185030137738\ \(0\)\
\-\ during\\:\\ 0\\.007829369011747928\ \(0\)\
\-\ renal\\:\\ 0\\.0076870525432876325\ \(0\)\
\-\ ultrasound\\:\\ 0\\.007590187380258393\ \(0\)\
\-\ abdomen\\:\\ 0\\.007578994799088912\ \(0\)\
\-\ demonstrated\\:\\ 0\\.007507245456457987\ \(0\)\
\-\ pulmonary\\:\\ 0\\.007474701527604981\ \(0\)\
\-\ level\\:\\ 0\\.007373919244451892\ \(0\)\
\-\ axial\\:\\ 0\\.007301770886430753\ \(0\)\
\-\ head\\:\\ 0\\.007256291349023641\ \(0\)\
\-\ region\\:\\ 0\\.007226350979758421\ \(0\)\
\-\ include\\:\\ 0\\.0071771062515876855\ \(0\)\
\-\ secondary\\:\\ 0\\.007152784330864694\ \(0\)\
\-\ history\\:\\ 0\\.007067152920401698\ \(0\)\
\-\ presented\\:\\ 0\\.006974124655755717\ \(0\)\
\-\ \\:\\:\\ 0\\.006768112670602785\ \(0\)\
\-\ patients\\:\\ 0\\.006621480836425228\ \(0\)\
\-\ prior\\:\\ 0\\.006569199916773544\ \(0\)\
\-\ surgery\\:\\ 0\\.00621257204898286\ \(0\)\
\-\ a\\:\\ 0\\.005937122781715588\ \(0\)\
\-\ demonstrate\\:\\ 0\\.00588758126147617\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005874908175989281\ \(0\)\
\-\ contrast\\:\\ 0\\.005726873313796124\ \(0\)\
\-\ may\\:\\ 0\\.0056117615835273174\ \(0\)\
\-\ female\\:\\ 0\\.005259761291759982\ \(0\)\
\-\ presents\\:\\ 0\\.0052264799266704375\ \(0\)\
\-\ patient\\:\\ 0\\.005129292999499329\ \(0\)\
\-\ is\\:\\ 0\\.005050515973515499\ \(0\)\
\-\ in\\:\\ 0\\.005046673414853353\ \(0\)\
\-\ the\\:\\ 0\\.004967040168992544\ \(0\)\
\-\ images\\:\\ 0\\.004907975724399264\ \(0\)\
\-\ disease\\:\\ 0\\.004181848925795522\ \(0\)\
\-\ as\\:\\ 0\\.0038699925326171492\ \(0\)\
\-\ of\\:\\ 0\\.0038369515232870442\ \(0\)\
\-\ from\\:\\ 0\\.0037917236920784803\ \(0\)\
\-\ mass\\:\\ 0\\.00355826648786696\ \(0\)\
\-\ an\\:\\ 0\\.0035379187553435027\ \(0\)\
\-\ pain\\:\\ 0\\.0031245753518884273\ \(0\)\
\-\ year\\:\\ 0\\.002862590626565613\ \(0\)\
\-\ and\\:\\ 0\\.0026947455947936893\ \(0\)\
\-\ old\\:\\ 0\\.0026195646612642356\ \(0\)\
\-\ to\\:\\ 0\\.002557294062532852\ \(0\)\
\-\ for\\:\\ 0\\.0021829585288704045\ \(0\)\
\-\ with\\:\\ 0\\.002101871426764486\ \(0\)\
